In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae
- 1 November 2000
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 38 (3), 177-179
- https://doi.org/10.1016/s0732-8893(00)00193-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- In Vitro Activities of Daptomycin, Vancomycin, Linezolid, and Quinupristin-Dalfopristin against Staphylococci and Enterococci, Including Vancomycin- Intermediate and -Resistant StrainsAntimicrobial Agents and Chemotherapy, 2000
- Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolatesDiagnostic Microbiology and Infectious Disease, 2000
- Synergy Testing of Vancomycin-Resistant Enterococcus faecium against Quinupristin-Dalfopristin in Combination with Other Antimicrobial AgentsAntimicrobial Agents and Chemotherapy, 1999
- In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant staphylococcus aureus and penicillin-resistant streptococcus pneumoniaeDiagnostic Microbiology and Infectious Disease, 1999
- Emergence of Fluoroquinolone Resistance among Multiply Resistant Strains of Streptococcus pneumoniae in Hong KongAntimicrobial Agents and Chemotherapy, 1999
- In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- t -Butylglycylamido Derivative of Minocycline (GAR-936)Antimicrobial Agents and Chemotherapy, 1999
- Treatment of Endocarditis Due to Vancomycin‐ResistantEnterococcus faeciumwith Quinupristin/Dalfopristin, Doxycycline, and Rifampin: A Synergistic Drug CombinationClinical Infectious Diseases, 1998
- Antimicrobial Activity of Quinupristin-Dalfopristin (RP 59500, Synercid®) Tested against Over 28,000 Recent Clinical Isolates from 200 Medical Centers in the United States and CanadaDiagnostic Microbiology and Infectious Disease, 1998
- Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococciJournal of Clinical Microbiology, 1997
- Emergence of Increased Resistance to Quinupristin/ Dalfopristin During Therapy for Enterococcus faecium BacteremiaClinical Infectious Diseases, 1997